VeriMomIst oligopeptide-20 in der Schwangerschaft sicher?
No harmonised CLP classification on reproductive toxicity (ECHA Annex VI), no CIR or SCCS safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenic or reproductive effects for oligopeptide‑20. As a synthetic oligopeptide (large, hydrophilic), dermal systemic absorption from cosmetic use is expected to be negligible, so exposure in pregnancy from topical use is essentially negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed search found no reproductive/toxicology reports).
Pregnancy-safe products containing oligopeptide-20
Related ingredients
Frequently asked questions
- Ist oligopeptide-20 in der Schwangerschaft sicher?
- No harmonised CLP classification on reproductive toxicity (ECHA Annex VI), no CIR or SCCS safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenic or reproductive effects for oligopeptide‑20. As a synthetic oligopeptide (large, hydrophilic), dermal systemic absorption from cosmetic use is expected to be negligible, so exposure in pregnancy from topical use is essentially negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed search found no reproductive/toxicology reports).
- Ist oligopeptide-20 während des Stillens sicher?
- No evidence of reproductive or lactation-related hazards in authoritative sources (no harmonised classification, no CIR/SCCS concerns, no peer‑reviewed data indicating transfer into milk). With negligible dermal absorption from topical cosmetic use, systemic exposure (and thus transfer into breastmilk) is expected to be negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed).
- Ist oligopeptide-20 sicher für Babyhaut?
- No evidence of developmental/infant toxicity or mechanistic reproductive hazard. However, because infant skin has a less mature barrier and higher surface‑area‑to‑weight, a conservative increase in exposure rating is applied (+1) despite peptide’s generally poor dermal penetration; adult systemic exposure is expected negligible, but infant exposure potential is low but measurable for topical application (sources: general dermal absorption principles, CosIng, PubChem; no infant‑specific studies found in PubMed).
- Wie bewertet VeriMom oligopeptide-20?
- VeriMom bewertet oligopeptide-20 mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu oligopeptide-20?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu oligopeptide-20 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.